Who
Mark Murcko
Director
Company insider
Files Form 4 as: Director, Relay Therapeutics.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 1
- Bought
- $500K
- Sold
- $749K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Jul 2020
- Last trade
- 9 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 10 Jun 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,947 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,947 at $0.00 | filing |
| 6 Jun 2025filed 6 Jun 2025 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —136,681 at $0.00 | filing |
| 3 Jun 2024filed 5 Jun 2024 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,225 at $0.00 | filing |
| 31 May 2023filed 1 Jun 2023 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,055 at $0.00 | filing |
| 8 Sep 2022filed 8 Sep 2022 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Sold | $749K25,000 at $29.95 | filing |
| 27 May 2022filed 27 May 2022 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,597 at $0.00 | filing |
| 19 May 2021filed 21 May 2021 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,000,000 at $0.00 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —990,099 at $0.00 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code C | —281,617 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Code C | —278,829 | filing |
| 20 Jul 2020filed 21 Jul 2020 | RLAY Relay TherapeuticsBiotechnology | SEC FORM 4 Bought | $500K25,000 at $20.00 | filing |
News
Head-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY)RLAY · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Mark Murcko; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.